# Glucagon-like Peptide 2 (GLP-2) in Undernourished Women Improving From Histology-Confirmed Environmental Enteric Dysfunction (EED)

> **NCT07537686** · PHASE2 · NOT_YET_RECRUITING · sponsor: **International Centre for Diarrhoeal Disease Research, Bangladesh** · enrollment: 55 (estimated)

## Conditions studied

- Environmental Enteric Dysfunction

## Interventions

- **DRUG:** Teduglutide 0.05 dose

## Key facts

- **NCT ID:** NCT07537686
- **Lead sponsor:** International Centre for Diarrhoeal Disease Research, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2027-10-01
- **Final completion:** 2027-12-30
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07537686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07537686, "Glucagon-like Peptide 2 (GLP-2) in Undernourished Women Improving From Histology-Confirmed Environmental Enteric Dysfunction (EED)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07537686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*